Literature DB >> 26219725

Mannose 6-phosphate-independent Lysosomal Sorting of LIMP-2.

Judith Blanz1, Friederike Zunke1, Sandra Markmann2, Markus Damme1, Thomas Braulke2, Paul Saftig1, Michael Schwake3.   

Abstract

The lysosomal integral membrane protein type 2 (LIMP-2/SCARB2) has been described as a mannose 6-phosphate (M6P)-independent trafficking receptor for β-glucocerebrosidase (GC). Recently, a putative M6P residue in a crystal structure of a recombinantly expressed LIMP-2 ectodomain has been reported. Based on surface plasmon resonance and fluorescence lifetime imaging analyses, it was suggested that the interaction of soluble LIMP-2 with the cation-independent M6P receptor (MPR) results in M6P-dependent targeting of LIMP-2 to lysosomes. As the physiological relevance of this observation was not addressed, we investigated M6P-dependent delivery of LIMP-2 to lysosomes in murine liver and mouse embryonic fibroblasts. We demonstrate that LIMP-2 and GC reach lysosomes independent of the M6P pathway. In fibroblasts lacking either MPRs or the M6P-forming N-acetylglucosamine (GlcNAc)-1-phosphotransferase, LIMP-2 still localizes to lysosomes. Immunoblot analyses also revealed comparable LIMP-2 levels within lysosomes purified from liver of wild-type (wt) and GlcNAc-1-phosphotransferase-defective mice. Heterologous expression of the luminal domain of LIMP-2 in wild-type, LIMP-2-deficient and GlcNAc-1-phosphotransferase-defective cells further established that the M6P modification is dispensable for lysosomal sorting of LIMP-2. Finally, cathepsin Z, a known GlcNAc-1-phosphotransferase substrate, but not LIMP-2, could be precipitated with M6P-specific antibodies. These data prove M6P-independent lysosomal sorting of LIMP-2 and subsequently GC in vivo.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Gaucher disease; LIMP-2/SCARB2; mannose 6-phosphate; mannose 6-phosphate receptor; β-glucocerebrosidase

Mesh:

Substances:

Year:  2015        PMID: 26219725     DOI: 10.1111/tra.12313

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  11 in total

1.  A versatile fluorescence-quenched substrate for quantitative measurement of glucocerebrosidase activity within live cells.

Authors:  Matthew C Deen; Yanping Zhu; Christina Gros; Na Na; Pierre-André Gilormini; David L Shen; Sandeep Bhosale; Nadia Anastasi; RuiQi Wang; Xiaoyang Shan; Eva Harde; Ravi Jagasia; Francis C Lynn; David J Vocadlo
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-12       Impact factor: 12.779

Review 2.  Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.

Authors:  Caleb Pitcairn; Willayat Yousuf Wani; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2018-03-14       Impact factor: 5.996

Review 3.  Molecular regulations and therapeutic targets of Gaucher disease.

Authors:  Yuehong Chen; Neetu Sud; Aubryanna Hettinghouse; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2018-04-11       Impact factor: 7.638

4.  Characterization of the complex formed by β-glucocerebrosidase and the lysosomal integral membrane protein type-2.

Authors:  Friederike Zunke; Lisa Andresen; Sophia Wesseler; Johann Groth; Philipp Arnold; Michelle Rothaug; Joseph R Mazzulli; Dimitri Krainc; Judith Blanz; Paul Saftig; Michael Schwake
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-21       Impact factor: 11.205

5.  Mutations in the X-linked ATP6AP2 cause a glycosylation disorder with autophagic defects.

Authors:  Maria A Rujano; Magda Cannata Serio; Ganna Panasyuk; Romain Péanne; Janine Reunert; Daisy Rymen; Virginie Hauser; Julien H Park; Peter Freisinger; Erika Souche; Maria Clara Guida; Esther M Maier; Yoshinao Wada; Stefanie Jäger; Nevan J Krogan; Oliver Kretz; Susana Nobre; Paula Garcia; Dulce Quelhas; Thomas D Bird; Wendy H Raskind; Michael Schwake; Sandrine Duvet; Francois Foulquier; Gert Matthijs; Thorsten Marquardt; Matias Simons
Journal:  J Exp Med       Date:  2017-11-10       Impact factor: 14.307

6.  Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2.

Authors:  Ria Thomas; Elizabeth B Moloney; Zachary K Macbain; Penelope J Hallett; Ole Isacson
Journal:  Mol Brain       Date:  2021-01-19       Impact factor: 4.041

7.  Leishmania amazonensis Engages CD36 to Drive Parasitophorous Vacuole Maturation.

Authors:  Kendi Okuda; Mei Tong; Brian Dempsey; Kathryn J Moore; Ricardo T Gazzinelli; Neal Silverman
Journal:  PLoS Pathog       Date:  2016-06-09       Impact factor: 6.823

8.  Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies.

Authors:  Karen S Conrad; Ting-Wen Cheng; Daniel Ysselstein; Saskia Heybrock; Lise R Hoth; Boris A Chrunyk; Christopher W Am Ende; Dimitri Krainc; Michael Schwake; Paul Saftig; Shenping Liu; Xiayang Qiu; Michael D Ehlers
Journal:  Nat Commun       Date:  2017-12-04       Impact factor: 14.919

Review 9.  Lysosomal and vacuolar sorting: not so different after all!

Authors:  Carine de Marcos Lousa; Jurgen Denecke
Journal:  Biochem Soc Trans       Date:  2016-06-15       Impact factor: 5.407

10.  Exploring new routes for secretory protein export from the trans-Golgi network.

Authors:  Mehrshad Pakdel; Julia von Blume
Journal:  Mol Biol Cell       Date:  2018-02-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.